ARTICLE | Company News
Emergent BioSolutions, PharmAthene, U.S. Department of Health and Human Services infectious news
June 14, 2010 7:00 AM UTC
PharmAthene said the Government Accountability Office denied Emergent's protest that an amended 2003 contract worth about $78 million between PharmAthene and HHS' Biomedical Advanced Research and Deve...